Image Source: The Financial Express

Agencies:

COVID-19: Clinical trial of Russia's sputnik vaccine to begin next month, including in India

8th-September-2020

The clinical trials of Russian Sputnik - V Coronavirus vaccine will begin next month in many countries, including India confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF).

In an interview to a Russian news network, Dmitriev said, "The Post registration studies involving more than 40,000 people started in Russia on August 26, before AstraZeneca has started its Phase 3 trial in the US with 30,000 participants. Clinical trials in Saudi Arabia, United Arab Emirates (UAE), the Philippines, India and Brazil will begin this month. The preliminary results of the Phase 3 trial will be published in October-November 2020."

The announcement comes just days after Russia shared its "comprehensive data" on the vaccine's safety with Indian authorities.

Following the publication of the results of Phase 1 and Phase 2 clinical trials of Sputnik-V in The lancet, India had asked for these details from the Gamaleya Research Institute of Epidemiology and Microbiology which is based in Moscow.

The Indo-Russian plans for the COVID-19 vaccine extends to "co-development", "co-production", "clinical trials".